US Patent Issued to BARINTHUS BIOTHERAPEUTICS NORTH AMERICA, THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER-NATIONAL INSTITUTES OF HEALTH on July 29 for "Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune response" (Maryland, District Of Columbia Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,370,255, issued on July 29, was assigned to BARINTHUS BIOTHERAPEUTICS NORTH AMERICA INC. (Germantown, Md.) and THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER-NATIONAL INSTITUTES OF HEALTH (Bethesda, Md.).

"Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune response" was invented by Geoffrey Martin Lynn (Baltimore) and Andrew Scott Ishizuka (Washington).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to novel peptide-based vaccines, methods of manufacturing the novel peptide-based vaccines and uses the...